Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Apr;84(4):378–384. doi: 10.1136/bjo.84.4.378

Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers

N Gangopadhyay 1, M Daniell 1, L Weih 1, H Taylor 1
PMCID: PMC1723447  PMID: 10729294

Abstract

AIM—To compare the clinical efficacy of commercially available fluoroquinolone drops with the use of combined fortified antibiotics (tobramycin 1.3%-cefazolin 5%) in treatment of bacterial corneal ulcer.
METHODS—The medical records of 140 patients with a diagnosis of bacterial corneal ulcer who were admitted to the Royal Victorian Eye and Ear Hospital, Melbourne, Australia between January 1993 and December 1997 were reviewed retrospectively. Final outcome and results of 138 ulcer episodes were compared between those treated initially with fluoroquinolone and those who received fortified antibiotics. Two patients had been treated with chloramphenicol.
RESULTS—No significant treatment difference was found between fluoroquinolone and fortified therapy in terms of final visual outcome. However, serious complications such as corneal perforation, evisceration, or enucleation of the affected eye were more common with fluoroquinolone therapy (16.7%) compared with the fortified therapy (2.4%, p= 0.02). The duration of intensive therapy was less with fluoroquinolone especially in those over 60 years of age (4 days v 6 days, p=0.01). Hospital stay was also less in the fluoroquinolone group compared with the fortified group for all patients and was significantly less with fluoroquinolone treatment (7 days v 10 days, p=0.02) in patients in the age group over 60 years old.
CONCLUSIONS—Monotherapy with fluoroquinolone eye drops for the treatment of bacterial corneal ulcers led to shorter duration of intensive therapy and shorter hospital stay compared with combined fortified therapy (tobramycin-cefazolin). This finding may have resulted from quicker clinical response of healing as a result of less toxicity found in the patients treated with fluoroquinolone. However, as some serious complications were encountered more commonly in the fluoroquinolone group, caution should be exercised in using fluoroquinolones in large, deep ulcers in the elderly.



Full Text

The Full Text of this article is available as a PDF (137.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum J. L., Barza M., Weinstein L. Preferred routes of antibiotic administration in treatment of bacterial ulcers of the cornea. Int Ophthalmol Clin. 1973 Winter;13(4):31–37. [PubMed] [Google Scholar]
  2. Baum J. L. Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms. Surv Ophthalmol. 1979 Sep-Oct;24(2):97–105. doi: 10.1016/0039-6257(79)90127-9. [DOI] [PubMed] [Google Scholar]
  3. Baum J. Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections. Trans Am Ophthalmol Soc. 1982;80:369–390. [PMC free article] [PubMed] [Google Scholar]
  4. Bowe B. E., Snyder J. W., Eiferman R. A. An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations. Am J Ophthalmol. 1991 Jun 15;111(6):686–689. doi: 10.1016/s0002-9394(14)76770-4. [DOI] [PubMed] [Google Scholar]
  5. Bower K. S., Kowalski R. P., Gordon Y. J. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol. 1996 Jun;121(6):712–715. doi: 10.1016/s0002-9394(14)70641-5. [DOI] [PubMed] [Google Scholar]
  6. Glasser D. B., Gardner S., Ellis J. G., Pettit T. H. Loading doses and extended dosing intervals in topical gentamicin therapy. Am J Ophthalmol. 1985 Mar 15;99(3):329–332. doi: 10.1016/0002-9394(85)90364-2. [DOI] [PubMed] [Google Scholar]
  7. Hyndiuk R. A., Eiferman R. A., Caldwell D. R., Rosenwasser G. O., Santos C. I., Katz H. R., Badrinath S. S., Reddy M. K., Adenis J. P., Klauss V. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology. 1996 Nov;103(11):1854–1863. doi: 10.1016/s0161-6420(96)30416-8. [DOI] [PubMed] [Google Scholar]
  8. Knauf H. P., Silvany R., Southern P. M., Jr, Risser R. C., Wilson S. E. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 1996 Jan;15(1):66–71. [PubMed] [Google Scholar]
  9. Kunimoto D. Y., Sharma S., Garg P., Rao G. N. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology. 1999 Jan;106(1):80–85. doi: 10.1016/S0161-6420(99)90008-8. [DOI] [PubMed] [Google Scholar]
  10. Leibowitz H. M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):34S–47S. [PubMed] [Google Scholar]
  11. McGarvey W. C., Singh D., Trevino S. G. Partial Achilles tendon ruptures associated with fluoroquinolone antibiotics: a case report and literature review. Foot Ankle Int. 1996 Aug;17(8):496–498. doi: 10.1177/107110079601700811. [DOI] [PubMed] [Google Scholar]
  12. O'Brien T. P., Maguire M. G., Fink N. E., Alfonso E., McDonnell P. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol. 1995 Oct;113(10):1257–1265. doi: 10.1001/archopht.1995.01100100045026. [DOI] [PubMed] [Google Scholar]
  13. Osborn E., Baum J. L., Ernst C., Koch P. The stability of ten antibiotics in artificial tear solutions. Am J Ophthalmol. 1976 Nov;82(5):775–780. doi: 10.1016/0002-9394(76)90016-7. [DOI] [PubMed] [Google Scholar]
  14. Parks D. J., Abrams D. A., Sarfarazi F. A., Katz H. R. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol. 1993 Apr 15;115(4):471–477. doi: 10.1016/s0002-9394(14)74449-6. [DOI] [PubMed] [Google Scholar]
  15. Wilhelmus K. R., Hyndiuk R. A., Caldwell D. R., Abshire R. L., Folkens A. T., Godio L. B. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group. Arch Ophthalmol. 1993 Sep;111(9):1210–1218. doi: 10.1001/archopht.1993.01090090062020. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES